Cilomni-10 Complete Guide: Cilnidipine 10 mg Tablets

Cilomni-10 is a prescription-only tablet marketed in India by EMK Omni Pharma, Mysuru. Each film-coated tablet contains Cilnidipine IP 10 mg together with approved excipients. The product is contract-manufactured at GMP-certified units and marketed by EMK Omni Pharma rather than made in its own plant.

It sits in the blood pressure management category. Doctors prescribe cilnidipine to adults whose blood pressure stays higher than the target they have set, either on its own or alongside other medicines. Because raised blood pressure usually causes no symptoms, the decision to start Cilomni-10 is based on repeated readings, your age, your kidney and heart health and other risk factors, not on how you feel on a given day.

Cilomni-10 carries the standard Schedule H warning: not to be sold by retail without the prescription of a registered medical practitioner.

Cilnidipine is a dihydropyridine calcium channel blocker. Calcium entering the muscle cells in the walls of your arteries makes those walls tighten. By slowing that calcium entry through L-type channels, cilnidipine allows the arteries to relax and widen. Wider arteries mean less resistance for the heart to push against, and blood pressure falls.

Cilnidipine has a second action that sets it apart within its class. It also blocks N-type calcium channels found at the endings of sympathetic nerves. Those nerve endings release noradrenaline, the chemical that speeds the heart and tightens vessels. Damping that release means the pulse is less likely to race in response to the vessel widening, and it is one reason ankle swelling is reported less often with cilnidipine than with some other medicines in the same family. This dual action is described in more detail in the article on the molecule itself.

The MRP printed on the carton is the maximum your chemist may charge. Always ask for a bill and check the batch number and expiry date before leaving the pharmacy.

Blood pressure treatment in India usually begins with lifestyle changes: less salt, more activity, weight control, less alcohol and stopping tobacco. Medicines are added when readings stay above target or when the overall cardiovascular risk is high.

Calcium channel blockers such as cilnidipine are one of the main groups doctors reach for, along with ARBs, ACE inhibitors and diuretics. Many people eventually need more than one medicine because each group works on a different part of the system. That is why EMK Omni Pharma also markets Cilomni-T 10/40, which pairs cilnidipine 10 mg with telmisartan 40 mg in a single tablet. Whether you need one molecule or two is a clinical decision, not a personal preference.

This hub page is the starting point. The other articles in this set go deeper into single questions.

Contact your doctor if you feel faint or unusually giddy when standing, if your ankles or feet swell, if headaches or flushing do not settle after the first week or two, or if your home readings drop much lower than the target you were given. Tell your doctor before starting any new medicine, including over-the-counter painkillers and Ayurvedic or herbal preparations, because some of them affect blood pressure control.

Never stop Cilomni-10 on your own because your readings have improved. Improved numbers usually mean the medicine is doing its job. Any change of dose, brand or schedule should come from the doctor who prescribed it.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.